Skip to main content
U2BIO CO., LTD. logo

U2BIO CO., LTD. — Investor Relations & Filings

Ticker · 221800 ISIN · KR7221800006 KO Human health and social work activities
Open in API
Filings indexed 227 across all filing types
Latest filing 2024-03-28 Declaration of Voting R…
Country KR South Korea
Listing KO 221800

About U2BIO CO., LTD.

https://www.u2bio.co.kr/eng/main.do

U2BIO CO., LTD. is a healthcare technology company specializing in the integration of biotechnology (BT) and information technology (IT). The company provides a range of in vitro diagnostic services, including clinical laboratory tests and molecular diagnostics. Concurrently, it develops and offers digital healthcare solutions and medical IT services tailored for medical institutions such as hospitals and clinics. U2BIO focuses on delivering personalized healthcare services based on scientific data to support medical professionals and improve patient health outcomes.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (Annual General Meeting). It details the outcomes of voting on agenda items such as financial statement approval, dividend declarations, election of directors and auditors, and amendments to business purposes. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2024-03-28 Korean
사업보고서 (2023.12)
Annual Report Classification · 100% confidence The document is a '사업보고서' (Business Report) for the 15th fiscal year (2023) of U2BIO Co., Ltd. It contains comprehensive information including company overview, history, capital changes, and business descriptions, which is characteristic of an Annual Report (10-K equivalent in the Korean regulatory context). FY 2023
2024-03-20 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from the Korean Exchange (KRX) titled '감사보고서 제출' (Submission of Audit Report). It provides a summary of financial data, audit opinions, and key financial metrics (assets, liabilities, revenue, etc.) as verified by an external auditor (Seohyun Accounting Corporation). While it contains financial data, it is a standard regulatory announcement form used to notify the market that the audit report has been submitted, rather than the full, multi-page audit report document itself. Therefore, it falls under the category of a regulatory filing announcement. FY 2023
2024-03-13 Korean
주주총회소집공고
AGM Information Classification · 100% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for U2Bio Co., Ltd. It includes the meeting date, location, agenda items (financial statements, dividend approval, board appointments, etc.), and proxy information. This is a standard document sent to shareholders to inform them of an upcoming Annual General Meeting (AGM). According to the provided definitions, materials shared for an AGM are classified as AGM-R.
2024-03-13 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company 'U2Bio'. It details the date, location, and specific agenda items for the upcoming Annual General Meeting (AGM), including the approval of financial statements, dividend decisions, and the election of directors and auditors. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the meeting and request their participation/votes. Therefore, it is classified as a Proxy Solicitation & Information Statement.
2024-02-15 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from 'U2Bio' regarding a decision on cash dividends ('현금ㆍ현물배당 결정'). It specifies the dividend amount per share, the record date, the total dividend amount, and the date of the board resolution. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2024-02-15 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.